Health & Personal Care
HIGH
FDA DRUG
Granules Pharmaceuticals Amphetamine Salts Recall Over Impurities Degradation Specifications (2025)
Granules Pharmaceuticals recalled 11,895 bottles of an extended-release amphetamine product due to failed impurities and degradation specifications. The recall is active nationwide in the United States. The FDA notice lists a high hazard level and urges stop-use and contact with the company or a healthcare provider.
Dextroamphetamine Saccharate
Failed Impurities/Degradation